Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Oncogenesis
|
May 26, 2018
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer
Aki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.
Hepatology (Baltimore, Md.)
|
February 23, 2021
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species
Derek Lee, Misty Shuo Zhang, Felice Ho-Ching Tsang, et al.
Journal of Hepatology
|
December 1, 2022
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses
Vincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.
Cell Reports
|
December 17, 2021
HLA-A<sup>∗</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses
Pavlo A Nesterenko, Jami McLaughlin, Brandon L Tsai, et al.
Cell Reports
|
January 27, 2021
Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer
Macus Hao-Ran Bao, Chunxue Yang, Aki Pui-Wah Tse, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2018
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma
Derek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2022
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
Cerise Yuen-Ki Chan, David Kung-Chun Chiu, Vincent Wai-Hin Yuen, et al.
Cell Reports. Medicine
|
November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Hepatology (Baltimore, Md.)
|
March 18, 2022
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity
Cerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Oncogenesis
|
May 26, 2018
Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer
Aki Pui-Wah Tse, Karen Man-Fong Sze, Queenie Tsung-Kwan Shea, et al.
Hepatology (Baltimore, Md.)
|
February 23, 2021
Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species
Derek Lee, Misty Shuo Zhang, Felice Ho-Ching Tsang, et al.
Journal of Hepatology
|
December 1, 2022
Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses
Vincent Wai-Hin Yuen, David Kung-Chun Chiu, Cheuk-Ting Law, et al.
Cell Reports
|
December 17, 2021
HLA-A<sup>∗</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses
Pavlo A Nesterenko, Jami McLaughlin, Brandon L Tsai, et al.
Cell Reports
|
January 27, 2021
Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer
Macus Hao-Ran Bao, Chunxue Yang, Aki Pui-Wah Tse, et al.
Hepatology (Baltimore, Md.)
|
December 19, 2018
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma
Derek Lee, Iris Ming-Jing Xu, David Kung-Chun Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2022
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma
Cerise Yuen-Ki Chan, David Kung-Chun Chiu, Vincent Wai-Hin Yuen, et al.
Cell Reports. Medicine
|
November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Hepatology (Baltimore, Md.)
|
March 18, 2022
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity
Cerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.
Page
of 8